Compare TENX & BLIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TENX | BLIN |
|---|---|---|
| Founded | 1967 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.8M | 15.4M |
| IPO Year | 2001 | 2018 |
| Metric | TENX | BLIN |
|---|---|---|
| Price | $10.73 | $1.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $29.67 | $4.62 |
| AVG Volume (30 Days) | ★ 619.3K | 51.1K |
| Earning Date | 05-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $13,568,000.00 |
| Revenue This Year | N/A | $22.67 |
| Revenue Next Year | N/A | $21.08 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.34 | $0.69 |
| 52 Week High | $18.38 | $1.74 |
| Indicator | TENX | BLIN |
|---|---|---|
| Relative Strength Index (RSI) | 35.14 | 51.96 |
| Support Level | $6.40 | $1.04 |
| Resistance Level | $14.15 | $1.09 |
| Average True Range (ATR) | 0.66 | 0.11 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 4.59 | 47.51 |
Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.
Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.